Following the close of its $18.1m Series B financing led by HealthQuest Capital with participation from Safeguard Scientifics, Inc. (NYSE:SFE), BioStar Ventures and other existing investors, Trice Medical, a King of Prussia, PA-based private diagnostics company focused on micro invasive technologies, appointed Craig Carra to the newly created position of Chief Financial Officer.
Mr. Carra is a medical device and service veteran with a 20-year career. His career started as an auditor with Coopers & Lybrand (PricewaterhouseCoopers). From 1996-2002, he served as Corporate Controller and Treasurer for Surgical Laser Technologies, a medical device company. From 2002-2012, Mr. Carra served as VP Sales and Business Development for PhotoMedex. Prior to Trice Medical, he served as the financial and business development leader for Ella Health, a venture backed, healthcare services company.
Mr. Carra holds a B.S. in Accounting (Magna Cum Laude) from Saint Joseph’s University and an Executive M.B.A. from Villanova University. Mr. Carra is a Certified Public Accountant.
Led by Jeffrey F. O’Donnell Sr., Chairman and CEO, Trice Medical has pioonered the mi-eye device, which is a fully disposable, single-use, streamlined visualization device that uses a standard 14-gauge needle with an integrated camera and light source to perform a diagnostic arthroscopy — while in the physician’s office during the initial consultation.
An LCD tablet, running on Android OS, is attached via a data cable from the mi-eye needle.